openPR Logo
Press release

Deadline on Dec. 28th coming up in Lawsuit for Investors in shares of Zosano Pharma Corporation (NASDAQ: ZSAN)

12-14-2020 07:17 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on December 28, 2020 in the lawsuit for certain investors in Zosano Pharma Corporation (NASDAQ: ZSAN).

A Deadline is coming up on December 28, 2020 in the lawsuit for certain investors in Zosano Pharma Corporation (NASDAQ: ZSAN).

A deadline is coming up on December 28, 2020 in the lawsuit filed for certain investors of Zosano Pharma Corporation (NASDAQ: ZSAN) over alleged securities laws violations by Zosano Pharma Corporatio.

Investors who purchased shares of Zosano Pharma Corporation (NASDAQ: ZSAN) have certain options and there are strict and short deadlines running. Deadline: December 28, 2020. NASDAQ: ZSAN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges on behalf of purchasers of Zosano Pharma Corporation (NASDAQ: ZSAN) common shares between February 13, 2017 and September 30, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 13, 2017 and September 30, 2020, the Defendants failed to disclose to investorsthat the Company’s clinical results reflected differences in zolmitriptan exposures observed between subjects receiving different lots, that pharmocokinetic studies submitted in connection with the Company’s NDA included patients exhibiting unexpected high plasma concentrations of zolmitriptan, that, as a result of the foregoing differences among patient results, the FDA was reasonably likely to require further studies to support regulatory approval of Qtrypta, that, as a result, regulatory approval of Qtrypta was reasonably likely to be delayed, and that as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

Those who purchased shares of Zosano Pharma Corporation (NASDAQ: ZSAN) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on Dec. 28th coming up in Lawsuit for Investors in shares of Zosano Pharma Corporation (NASDAQ: ZSAN) here

News-ID: 2209538 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Zosano

Cluster Headache Market to Worth $550.1 Million, Growing at 6.4% by 2028 | Zosan …
The global cluster headache market is estimated to be valued at US$ 355.2 Million in 2021 and is expected to increase to US$ 550.1 Million by 2028, witnessing a CAGR of 6.4% over the forecast period (2021-2028). Cluster headache is one of the most severe type of headache, as it occurs in cyclical patterns or cluster periods. Cluster episodes, which last from weeks to months, are frequently followed by remission periods,
Microneedle Drug Delivery Systems Market 2021 Global Outlook - 3M, Zosano Pharma …
The “Microneedle Drug Delivery Systems Market” report is an in-depth study of the market, along with an analysis of its key segments. The relationship is built through extensive primary and secondary research. In-depth market data is generated through interviews and data collection from industry experts and professionals. The study is a detailed document on key aspects of the markets including trends, segmentation, growth prospects, opportunities, challenges, and competitive analysis. The report is
Investigation announced for Investors in NASDAQ: ZSAN shares over potential Wron …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Zosano Pharma Corporation. Investors who are current long term investors in Zosano Pharma Corporation (NASDAQ: ZSAN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: ZSAN stocks follows a lawsuit filed against Zosano Pharma Corporation
Lawsuit filed for Investors in shares of Zosano Pharma Corporation (NASDAQ: ZSAN …
An investor, who purchased shares of Zosano Pharma Corporation (NASDAQ: ZSAN), filed a lawsuit over alleged violations of Federal Securities Laws by Zosano Pharma Corporation. Investors who purchased shares of Zosano Pharma Corporation (NASDAQ: ZSAN) have certain options and for certain investors are short and strict deadlines running. Deadline: December 28, 2020. NASDAQ: ZSAN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Fremont, CA based Zosano
World Microneedle Drug Delivery Systems Market 2020, Covid Imapct Analysis - 3M, …
The Microneedle Drug Delivery Systems market research report provides a thorough overview of market status and trend creation, including key player categories, applications, growth, opportunities, growing technology, competitive landscape and product offerings. Microneedle Drug Delivery Systems Business Research covers current and past market conditions, industry trends, and is expected to continue to develop over the Forecast Period Companies Profiled in this report includes: Merck, AJ PHARMA (Statens Serum Institut (SSI)), Japan
Explosive Growth on Biologics Outsourcing Market 2019-2026: Global Companies lik …
The Biologics Outsourcing market size is expected to reach at a CAGR of +17% during the forecast period according to new report. Global Biologics Outsourcing Market peaks the detailed analysis of industry share, growth factors, development trends, size. The report also analyze innovative business strategies, value added factors and business opportunities. Biologics bring into picture higher range of specificity in treating a disease condition as the biologic entities like monoclonal